A promising action of riboflavin as a mediator of leukaemia cell death
10.1007/s10495-006-9549-2
Crossref journal-article
Springer Science and Business Media LLC
Apoptosis (297)
Bibliography

de Souza, A. C. S., Kodach, L., Gadelha, F. R., Bos, C. L., Cavagis, A. D. M., Aoyama, H., Peppelenbosch, M. P., & Ferreira, C. V. (2006). A promising action of riboflavin as a mediator of leukaemia cell death. Apoptosis, 11(10), 1761–1771.

Authors 8
  1. Ana Carolina Santos de Souza (first)
  2. Liudmila Kodach (additional)
  3. Fernanda R. Gadelha (additional)
  4. Carina L. Bos (additional)
  5. Alexandre D. Martins Cavagis (additional)
  6. Hiroshi Aoyama (additional)
  7. Maikel P. Peppelenbosch (additional)
  8. Carmen Veríssima Ferreira (additional)
References 40 Referenced 46
  1. Peng Q, Nesland JM (2004) Effects of photodynamic therapy on tumor stroma. Ultrastruct Pathol 28:333–340 (10.1080/01913120490515586) / Ultrastruct Pathol by Q Peng (2004)
  2. Edwards AM, Barredo F, Silva E, De Ioannes AE, Becker MI (1999b) Apoptosis induction in nonirradiated human HL60 and murine NOS/2 tumor cells by photoproducts of índole-3-acetic acid and riboflavin. Photochem Photobiol 70:645–649 / Photochem Photobiol by AM Edwards (1999)
  3. Souza ACS, Cavagis ADM, Jucá MB, Ferreira CV, Aoyama H, Peppelenbosch MP (2005) Riboflavin: a multifunctional vitamin. Quim Nova 28:887–891 (10.1590/S0100-40422005000500028) / Quim Nova by ACS Souza (2005)
  4. Meisel D, Neta P (1975) One electron reduction potential of riboflavin studied by pulse radiolysis. J Phys Chem 79:2459–2461 (10.1021/j100590a002) / J Phys Chem by D Meisel (1975)
  5. Ahmad I, Fasihullah Q, Noor A, Ansari IA, Ali QNM (2004a) Photolysis of riboflavin in aqueous solution: a kinetic study. Int J Pharm 280:199–208 (10.1016/j.ijpharm.2004.05.020) / Int J Pharm by I Ahmad (2004)
  6. Ahmad I, Fasihullah Q, Vaid FHM (2004b) A study of simultaneous photolysis and photoaddition reactions of riboflavin in aqueous solution. J Photochem Photobiol B: Biol 75:13–20 (10.1016/j.jphotobiol.2004.04.001) / J Photochem Photobiol B: Biol by I Ahmad (2004)
  7. Holzer W, Shirdel J, Penzkofer AH, Deutzmann R, Hochmuth E (2005) Photo-induced degradation of some flavins in aqueous solution. Chem Phys 308:69–78 (10.1016/j.chemphys.2004.08.006) / Chem Phys by W Holzer (2005)
  8. Silva E, Ugarte R, Andrade A, Edwards AM (1994) Riboflavin-sensitized photoprocesses of tryptophan. J Photochem Photobiol B: Biol 23:43–48 (10.1016/1011-1344(93)06984-B) / J Photochem Photobiol B: Biol by E Silva (1994)
  9. Edwards AM, Silva E (2001) Effect of visible light on selected enzymes, vitamins and amino acids. J Photochem Photobiol B: Biol 63:126–131 (10.1016/S1011-1344(01)00209-3) / J Photochem Photobiol B: Biol by AM Edwards (2001)
  10. Edwards AM, Bueno C, Saldaño A, Kassab K, Polo L, Jori G (1999a) Photochemical and pharmacokinetc properties of select flavins. J Photochem Photobiol B: Biol 48:36–41 (10.1016/S1011-1344(99)00006-8) / J Photochem. Photobiol B: Biol by AM Edwards (1999)
  11. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Meth 65:55–63 (10.1016/0022-1759(83)90303-4) / J Immunol Meth by T Mosmann (1983)
  12. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Meth 89:71–77 (10.1016/0022-1759(86)90368-6) / J Immunol Meth by F Denizot (1986)
  13. Akerman KE, Wikstrom MK (1976) Safranine as a probe of the mitochondrial membrane potential. FEBS Lett 68:191–197 (10.1016/0014-5793(76)80434-6) / FEBS Lett by KE Akerman (1976)
  14. Hartree EF (1972) Determination of proteins: a modification of Lowry method that give a linear photometric response. Anal Biochem 48:422–427 (10.1016/0003-2697(72)90094-2) / Anal Biochem by EF Hartree (1972)
  15. Edwards AM, Silva E, Jofré B, Becker MI, De Ioannes AE (1994) Visible light effects on tumoral cells in a culture medium enriched with tryptophan and riboflavin. J Photochem Photobiol B: Biol 24:179–186 (10.1016/1011-1344(94)07020-2) / J Photochem Photobiol B: Biol by AM Edwards (1994)
  16. Siskind LJ (2005) Mitochondrial Ceramide and the induction of apoptosis. J Bioenergetics and Biomembranes 37:143–153 (10.1007/s10863-005-6567-7) / J Bioenergetics and Biomembranes by LJ Siskind (2005)
  17. Cremesti AE, Goni FM, Kolesnick R (2002) Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett 531:47–53 (10.1016/S0014-5793(02)03489-0) / FEBS Lett by AE Cremesti (2002)
  18. Huang ST, Yang RC, Chen MY, Pang JH (2004) Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in Hl60 cells. Life Sci 75:339–351 (10.1016/j.lfs.2003.12.013) / Life Sci by ST Huang (2004)
  19. Miyaji M, Jin ZX, Yamaoka S, Amakawa R, Fukuhara S, Sato SB, Kobayashi T, Domae N, Mimori T, Bloom ET, Okazaki T, Umehara H (2005) Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J Exp Med 202:249–259 (10.1084/jem.20041685) / J Exp Med by M Miyaji (2005)
  20. Rotolo JA, Zhang J, Donepudi M, Lee H, Fuks Z, Kolesnick R (2005) Caspase-dependent and–independent activation of acid sphingomyelinase signaling. J Biol Chem 280:26425–26434 (10.1074/jbc.M414569200) / J Biol Chem by JA Rotolo (2005)
  21. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN (1996) Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75–79 (10.1038/380075a0) / Nature by M Verheij (1996)
  22. Hetz CA, Hunn M, Rojas P, Torres V, Leyton L, Quest AF (2002) Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase. J Cell Sci 115:4671–4683 (10.1242/jcs.00153) / J Cell Sci by CA Hetz (2002)
  23. Huang H, Chen Y, Wu Y (2005) Mitochondria-dependent apoptosis induced by a novel amphipathic photochemotherapeutic agent ZnPcS2P2 in HL60 cells. Acta Pharmacol Sin 26:1138–1144 (10.1111/j.1745-7254.2005.00160.x) / Acta Pharmacol Sin by H Huang (2005)
  24. Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP, Levison DA (1991) The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 19:21–27 (10.1111/j.1365-2559.1991.tb00890.x) / Histopathology by AL Woods (1991)
  25. Xia L, Zheng L, Lee HW, Bates SE, Federico L, Shen B, O’Connor TR (2005) Human 3-methyladenine-DNA glycosylase: effect of sequence context on excision, association with PCNA, and stimulation by AP endonuclease. J Mol Biol 346:1259–1274 (10.1016/j.jmb.2005.01.014) / J Mol Biol by L Xia (2005)
  26. Steinman RA, Huang J, Yaroslavskiy B, Goff JP, Ball ED, Nguyen A (1998) Regulation of p21 (WAF1) expression during normal myeloid differentiation. Blood 91:4531–4542 (10.1182/blood.V91.12.4531) / Blood by RA Steinman (1998)
  27. Wang Y, Wu TR, Cai S, Welte T, Chin YE (2000) Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol Cell Biol 20:4505–4512 (10.1128/MCB.20.13.4505-4512.2000) / Mol Cell Biol by Y Wang (2000)
  28. Das D, Pintucci G, Stern A (2000) MAPK-dependent expression of p21(WAF) and p27(kip1) in PMA-induced differentiation of HL60 cells. FEBS Lett 472:50–52 (10.1016/S0014-5793(00)01416-2) / FEBS Lett by D Das (2000)
  29. Asada M, Ohmi K, Delia D, Enosawa S, Suzuki S, You A, Suzuki H, Mizutani S (2004) Brap2 functions as a cytoplasmic retention protein for p21 during monocyte differentiation. Mol Cell Biol 24:8236–8243 (10.1128/MCB.24.18.8236-8243.2004) / Mol Cell Biol by M Asada (2004)
  30. Zhang ZY (2003) Chemical and mechanistic approaches to the study of protein tyrosine phosphatases. Acc Chem Res 36:385–92 (10.1021/ar020122r) / Acc Chem Res by ZY Zhang (2003)
  31. Aoyama H, Silva TMA, Miranda MA, Ferreira CV (2003) Proteínas tirosina fosfatases: propriedades e funções biológicas. Quim Nova 26:896–900 (10.1590/S0100-40422003000600019) / Quim Nova by H Aoyama (2003)
  32. McCluskey A, Ackland SP, Bowyer MC, Baldwin ML, Garner J, Walkom CC, Sakoff JA (2003) Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumor cell lines. Bioorg Chem 31:68–79 (10.1016/S0045-2068(02)00524-2) / Bioorg Chem by A McCluskey (2003)
  33. Uzunoglu S, Uslu R, Tobu M, Saydam G, Terzioglu E, Buyukkececi F, Omay SB (1999) Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine phosphatase inhibitors. Leuk Res 23:507–512 (10.1016/S0145-2126(99)00040-5) / Leuk Res by S Uzunoglu (1999)
  34. Bhoola R, Hammond K (2000) Modulation of the rhythmic patterns of expression of phosphoprotein phosphatases in human leukaemia cells. Cell Biol Int 24:539–547. (10.1006/cbir.2000.0568) / Cell Biol Int by R Bhoola (2000)
  35. Brantley-Finley C, Lyle CS, Du L, Goodwin ME, Hall TS, DK, G P, Chambers T (2003) The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem Pharmacol 66:459–469 (10.1016/S0006-2952(03)00255-7)
  36. Lee JT Jr, McCubrey JA (2002) The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16:486–507 (10.1038/sj.leu.2402460) / Leukemia by JT Lee Jr (2002)
  37. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68:320–344 (10.1128/MMBR.68.2.320-344.2004) / Microbiol Mol Biol Rev by PP Roux (2004)
  38. Chen F, Wang Q, Wang X and Studzinski GP (2004) Up-regulation of Egr1 by 1,25-dihydroxyvitamin D3 contributes to increased expression of p35 activator of cyclin-dependent kinase 5 and consequent onset of the terminal phase of HL60 cell differentiation. Cancer Res 64:5425–5433 (10.1158/0008-5472.CAN-04-0806) / Cancer Res by F Chen (2004)
  39. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE (2000) MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J 19:5418–5428 (10.1093/emboj/19.20.5418) / EMBO J by TH Holmstrom (2000)
  40. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE (2001) MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem 276:16484–1690 (10.1074/jbc.M010384200) / J Biol Chem by SE Tran (2001)
Dates
Type When
Created 19 years ago (Aug. 25, 2006, 6:26 a.m.)
Deposited 5 years, 4 months ago (April 17, 2020, 8:05 p.m.)
Indexed 3 weeks, 4 days ago (Aug. 3, 2025, 7:04 p.m.)
Issued 19 years ago (Aug. 21, 2006)
Published 19 years ago (Aug. 21, 2006)
Published Online 19 years ago (Aug. 21, 2006)
Published Print 18 years, 10 months ago (Oct. 1, 2006)
Funders 0

None

@article{de_Souza_2006, title={A promising action of riboflavin as a mediator of leukaemia cell death}, volume={11}, ISSN={1573-675X}, url={http://dx.doi.org/10.1007/s10495-006-9549-2}, DOI={10.1007/s10495-006-9549-2}, number={10}, journal={Apoptosis}, publisher={Springer Science and Business Media LLC}, author={de Souza, Ana Carolina Santos and Kodach, Liudmila and Gadelha, Fernanda R. and Bos, Carina L. and Cavagis, Alexandre D. Martins and Aoyama, Hiroshi and Peppelenbosch, Maikel P. and Ferreira, Carmen Veríssima}, year={2006}, month=aug, pages={1761–1771} }